Patient Access to Alternative Treatments:
Beyond the FDA

February 23, 1998

The House Committee on Government Reform and Oversight held public hearings to examine the current availability of alternative treatments to desperately ill Americans. The Committee heard from Members of Congress, patients and professionals who testified about the barriers to access they have faced, and the need for legislative changes to meet growing consumer demand for access to safe and efficacious therapeutic options.

Hearing Dates

• February 12, 1998
• February 4, 1998

February 12, 1998

	Chairman Dan Burton, Opening Statement
	Honorable Peter DeFazio (D-Oregon)
	Honorable James Moran (D-Virginia)
	Honorable Ed Gochenour (Georgia State Senator)
	Dr. Lyle E. Cheadle and his daughter Janet
	Tammy Geurkink Born, MD
	Peter Mattiessen, MD
	James S. Gordon, MD

February 4, 1998

	Chairman Dan Burton, Opening Statement
	Honorable Peter Bedell (Former Congressman)
	Mr. Jack Kunnari
	Ms. Becky Nippert
	Ms. Genevieve Sherman
	Ms. Mary Jo Siegel
	Ms. Ann Fonfa, MD
	Mr. Jonathan W. Emord (Attorney)
	Dr. Charles B. Simone (Oncologist and Cancer Researcher)
	Mr. Ralph Moss, Ph.D.
	Dr. Arnold Eggers (Cancer Researcher)
	Mr. Thomas J. Moore (Senior Fellow, Health Policy Institute, George Washington University)

1825 Eye Street, N.W., Suite 400
Washington, DC 20006

Tel: (202) 429-6610
Fax: (202) 861-1973